Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) SVP Patricia Wadors sold 1,078 shares of the stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $478,416.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Intuitive Surgical Stock Performance
Shares of ISRG stock opened at $451.63 on Tuesday. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The firm has a market capitalization of $156.55 billion, a PE ratio of 54.61, a PEG ratio of 3.12 and a beta of 1.46. The stock has a fifty day simple moving average of $396.06 and a two-hundred day simple moving average of $437.59.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter in the prior year, the firm earned $2.40 EPS. The business's revenue was up 21.7% on a year-over-year basis. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.
More Intuitive Surgical News
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: Analysts’ earnings estimates for ISRG are moving higher, suggesting improving expectations for the company’s near-term results and potentially supporting further gains. Earnings Estimates Moving Higher for Intuitive Surgical
- Positive Sentiment: Recent research continues to highlight Intuitive Surgical’s growth characteristics, including the potential for its robotic-surgery franchise to outperform the broader market over time. Intuitive Surgical Is an Incredible Growth Stock
- Neutral Sentiment: Intuitive Surgical remains a heavily watched stock, which may increase trading interest but does not by itself indicate a change in the company’s fundamentals. Intuitive Surgical Is a Trending Stock
- Neutral Sentiment: Reported short interest of zero shares and a zero-day days-to-cover ratio appears inconsistent with the description of a “significant increase,” making the data of limited value for gauging investor positioning.
- Negative Sentiment: Multiple insiders sold shares under pre-arranged Rule 10b5-1 plans. Director Gary Guthart sold about $9.1 million of stock, while other executives and a director sold additional shares. The transactions were planned and Guthart retained more than 1.2 million shares, but the sales may still create modest sentiment pressure.
- Negative Sentiment: Investors remain sensitive to valuation risk: with a high earnings multiple, ISRG may need continued strong growth and upward estimate revisions to justify its price.
Institutional Trading of Intuitive Surgical
A number of institutional investors have recently modified their holdings of the company. SYM FINANCIAL Corp purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at approximately $280,000. Autumn Glory Partners LLC boosted its stake in Intuitive Surgical by 7.3% in the 3rd quarter. Autumn Glory Partners LLC now owns 3,587 shares of the medical equipment provider's stock worth $1,459,000 after purchasing an additional 244 shares in the last quarter. Independence Bank of Kentucky grew its position in Intuitive Surgical by 15.9% during the 3rd quarter. Independence Bank of Kentucky now owns 1,607 shares of the medical equipment provider's stock worth $653,000 after purchasing an additional 220 shares during the last quarter. Abundance Wealth Counselors purchased a new stake in Intuitive Surgical during the 3rd quarter worth approximately $206,000. Finally, Center for Financial Planning Inc. grew its position in Intuitive Surgical by 64.4% during the 3rd quarter. Center for Financial Planning Inc. now owns 753 shares of the medical equipment provider's stock worth $306,000 after purchasing an additional 295 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
ISRG has been the subject of a number of recent analyst reports. Citigroup dropped their price objective on Intuitive Surgical from $590.00 to $500.00 and set a "buy" rating for the company in a report on Friday, July 17th. Raymond James Financial reiterated an "outperform" rating and issued a $480.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 21st. BTIG Research reiterated a "buy" rating and set a $454.00 target price on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Zacks Research upgraded Intuitive Surgical from a "hold" rating to a "strong-buy" rating in a research report on Thursday, October 22nd. Finally, BMO Capital Markets reissued an "outperform" rating on shares of Intuitive Surgical in a research note on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $493.54.
Read Our Latest Stock Report on ISRG
About Intuitive Surgical
(
Get Free Report)
Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company's primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.
The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
